Replies to post #15517 on Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[leifsmith]

You write that Mullan is "going there for the money." Sure, like you and me, he likes to be paid. But if you mean to imply that this man is not a real scientist dedicated to brain science and health, I think you've got him wrong.

That kind of cynicism will also fail to stop the recognition of the value of anatabine.

[tmf1955]

Dr. Mullan coming to STAR for the money is an interesting point. Are you talking about the salary? Is it a great improvement from what he was making as CEO of Roskamp? Or is it that with stock and options that he feels like he could make a whole lot more? Or did he take this position because he feels strongly about the potential for anatabine in helping him fulfill his life long work in treating various conditions, such as alzhiemer's disease. Switching from CEO of Roskamp to CEO of STAR doesn't make a lot of sense if STAR is a dead end, does it? There is evidently more here than you would like to believe, or admit. Still a great short? At this price level, I beg to differ. The chances now for making money as a short are overwhelmed by the potential upside. But hang in there. We will see what the tree shakes loose.